1.
Quantitative Analysis for Jak2 Mutation in 98 Patients with Essential Thrombocythemia and Its Clinical Significance
98例原发性血小板增多症Jak2基因突变的定量分析及其临床意义
2.
JAK2V617F Point Mutation in Hematological Malignancies;
慢性骨髓增生性疾病JAK2基因V617F点突变研究
3.
Study on the relationship between KLF4 and JAK2 V617F point mutation
KLF4基因表达与JAK2 V617F点突变的关联性研究
4.
Study on Expression of JAK2 Mutation in Patients with Chronic Myeloproliferative Diseases and Its Targeted Therapy in Vitro;
慢性骨髓增殖性疾病JAK2基因突变发生情况及其靶向治疗的研究
5.
Clinic Study on Expression of JAK2 and MPL Mutations in Patients with Chronic Myeloproliferative Diseases;
慢性骨髓增殖性疾病JAK2及MPL基因突变的临床研究
6.
Identification of an JAK2 Mutation in Chronic Myeloproliferative Disorders by dFARMS;
dFARMS检测慢性骨髓增殖性疾病JAK2基因的V617F点突变的研究
7.
Study on JAK2 V617F point mutation in 141 patients with chronic myeloproliferatives diseases
141例慢性骨髓增生性疾病中JAK2基因V617F点突变的研究
8.
Study on the Prevalence of Protein Tyrosine Kinase JAK2V617F Mutation in the Western Population;
西方人群中蛋白质酪氨酸激酶JAK2~（V617F）突变率研究
9.
JAK2~(V617F) Point Mutation in Patients with Polycythemia Vera;
真性红细胞增多症患者JAK2~（V617F）点突变的研究
10.
The Expression and Clinical Significance of JAK2, SOCS1, SOCS2 and SHP-1 in Leukemia;
JAK2、SOCS1、SOCS2和SHP-1基因在白血病中的表达及意义
11.
The Effect of JAK2/STAT3 Signal Pathway on the Transcription of Lipogenesis and Lipolysis Genes in Mice
JAK2/STAT3通路对小鼠生脂和脂解基因转录的影响
12.
Study on the Prevalence of Protein Tyrosine Kinase JAK2～(V617F) Mutation in the Chinese Population;
蛋白质酪氨酸激酶JAK2～（V617F）突变在中国人群中的发生率研究
13.
JAK2 V617F mutation in BCR-ABL negative patients with myeloproliferative disorder and its clinic significance
BCR-ABL阴性骨髓增殖性疾病患者JAK2 V617F突变的检测及其临床意义
14.
Detection of V617F point mutation of JAK2 gene by AS-PCR in chronic myeloproliferative disease and its clinical significance
AS-PCR检测慢性骨髓增殖性疾病JAK2 V617点突变及临床意义
15.
missense suppressor
错义（突变）抑制基因，错义（突变）抑制因子
16.
suppressor sensitive mutant
抑制基因敏感突变型
17.
Mutant Gene "Sparked Art and Culture"
基因突变 文明曙光
18.
ATP7A Genetic Analysis of Menkes Disease;
Menkes病的ATP7A基因突变分析